Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Tarak Srivastava to Child

This is a "connection" page, showing publications Tarak Srivastava has written about Child.

 
Connection Strength
  
 
 
1.310
  
  1. Srivastava T, Ju W, Milne GL, Rezaiekhaligh MH, Staggs VS, Alon US, Sharma R, Zhou J, El-Meanawy A, McCarthy ET, Savin VJ, Sharma M. Urinary prostaglandin E2 is a biomarker of early adaptive hyperfiltration in solitary functioning kidney. Prostaglandins Other Lipid Mediat. 2020 02; 146:106403.
    View in: PubMed
    Score: 0.093
  2. Srivastava T, Garg U, Ruiz M, Dai H, Alon US. Serum 25(OH)-vitamin D level in children: is there a need to change the reference range based on 2011 Institute of Medicine report? Clin Pediatr (Phila). 2013 Feb; 52(2):178-82.
    View in: PubMed
    Score: 0.053
  3. Srivastava T, Dai H, Haney CJ, Alon US. Serum 25-hydroxyvitamin D level and acute-phase reaction following initial intravenous bisphosphonate. J Bone Miner Res. 2011 Feb; 26(2):437-8.
    View in: PubMed
    Score: 0.050
  4. Srivastava T, Winston MJ, Auron A, Alon US. Urine calcium/citrate ratio in children with hypercalciuric stones. Pediatr Res. 2009 Jul; 66(1):85-90.
    View in: PubMed
    Score: 0.045
  5. Srivastava T, Schwaderer A. Diagnosis and management of hypercalciuria in children. Curr Opin Pediatr. 2009 Apr; 21(2):214-9.
    View in: PubMed
    Score: 0.044
  6. Srivastava T, Haney CJ, Alon US. Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion. J Bone Miner Res. 2009 Feb; 24(2):334-7.
    View in: PubMed
    Score: 0.044
  7. Srivastava T, Alon US, Althahabi R, Garg U. Impact of standardization of creatinine methodology on the assessment of glomerular filtration rate in children. Pediatr Res. 2009 Jan; 65(1):113-6.
    View in: PubMed
    Score: 0.043
  8. Srivastava T, Alon US. Pathophysiology of hypercalciuria in children. Pediatr Nephrol. 2007 Oct; 22(10):1659-73.
    View in: PubMed
    Score: 0.039
  9. Srivastava T, Garg U, Chan YR, Alon US. Essentials of laboratory medicine for the nephrology clinician. Pediatr Nephrol. 2007 Feb; 22(2):170-82.
    View in: PubMed
    Score: 0.037
  10. Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr Nephrol. 2006 Apr; 21(4):463-70.
    View in: PubMed
    Score: 0.036
  11. Maniar A, Gipson DS, Brady T, Srivastava T, Selewski DT, Greenbaum LA, Dell KM, Kaskel F, Massengill S, Tran C, Trachtman H, Lafayette R, Almaani S, Hingorani S, Wang CS, Reidy K, Cara-Fuentes G, Gbadegesin R, Myers K, Sethna CB. Growth in children with nephrotic syndrome: a post hoc analysis of the NEPTUNE study. Pediatr Nephrol. 2024 Sep; 39(9):2691-2701.
    View in: PubMed
    Score: 0.031
  12. Schuchman M, Brady TM, Glenn DA, Tuttle KR, Cara-Fuentes G, Levy RV, Gonzalez-Vicente A, Alakwaa FM, Srivastava T, Sethna CB. Association of mental health-related patient reported outcomes with blood pressure in adults and children with primary proteinuric glomerulopathies. J Nephrol. 2024 Apr; 37(3):647-660.
    View in: PubMed
    Score: 0.031
  13. Carboni J, Thomas E, Gipson DS, Brady TM, Srivastava T, Selewski DT, Greenbaum LA, Wang CS, Dell KM, Kaskel F, Massengill S, Reidy K, Tran CL, Trachtman H, Lafayette R, Almaani S, Hingorani S, Gbadegesin R, Gibson KL, Sethna CB. Longitudinal analysis of blood pressure and lipids in childhood nephrotic syndrome. Pediatr Nephrol. 2024 Jul; 39(7):2161-2170.
    View in: PubMed
    Score: 0.031
  14. Srivastava T, Alon US. The role of bisphosphonates in diseases of childhood. Eur J Pediatr. 2003 Nov; 162(11):735-51.
    View in: PubMed
    Score: 0.030
  15. Riar S, Srivastava T, George R. Transition of Care in Children with Chronic Kidney Disease, Dialysis, and Transplantation. Indian J Pediatr. 2023 Dec; 90(12):1237-1244.
    View in: PubMed
    Score: 0.030
  16. Hingorani S, Gibson KL, Xie Y, Wang Y, Eddy S, Hartman J, Sampson M, Cassol C, Thomas D, Gipson DS, Trachtman H, Srivastava T, Reidy K. The association of low birthweight and prematurity on outcomes in children and adults with nephrotic syndrome-a NEPTUNE cohort study. Pediatr Nephrol. 2023 10; 38(10):3297-3308.
    View in: PubMed
    Score: 0.029
  17. Srivastava T, Garola RE, Whiting JM, Alon US. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood. Kidney Int. 2003 Apr; 63(4):1374-81.
    View in: PubMed
    Score: 0.029
  18. Wang L, Smith-Salzberg B, Meyers KE, Glenn DA, Tuttle KR, Derebail VK, Brady TM, Gibson K, Smith AR, O'Shaughnessy MM, Srivastava T, Hall G, Zee J, Bitzer M, Sethna CB. Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study. BMC Nephrol. 2023 02 09; 24(1):30.
    View in: PubMed
    Score: 0.029
  19. Chen DP, Helmuth ME, Smith AR, Canetta PA, Ayoub I, Mucha K, Kallash M, Kopp JB, Gbadegesin R, Gillespie BW, Greenbaum LA, Parekh RS, Hunley TE, Sperati CJ, Selewski DT, Kidd J, Chishti A, Reidy K, Mottl AK, Gipson DS, Srivastava T, Twombley KE. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network. Am J Kidney Dis. 2023 06; 81(6):695-706.e1.
    View in: PubMed
    Score: 0.029
  20. Gipson DS, Troost JP, Spino C, Attalla S, Tarnoff J, Massengill S, Lafayette R, Vega-Warner V, Adler S, Gipson P, Elliott M, Kaskel F, Fermin D, Moxey-Mims M, Fine RN, Brown EJ, Reidy K, Tuttle K, Gibson K, Lemley KV, Greenbaum LA, Atkinson MA, Hingorani S, Srivastava T, Sethna CB, Meyers K, Tran C, Dell KM, Wang CS, Yee JL, Sampson MG, Gbadegesin R, Lin JJ, Brady T, Rheault M, Trachtman H. Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis. JAMA Netw Open. 2022 08 01; 5(8):e2228701.
    View in: PubMed
    Score: 0.028
  21. Srivastava T, O'Neill JP, Dasouki M, Simckes AM. Childhood hyperuricemia and acute renal failure resulting from a missense mutation in the HPRT gene. Am J Med Genet. 2002 Mar 15; 108(3):219-22.
    View in: PubMed
    Score: 0.027
  22. Srivastava T, Alon US. Pneumonia-associated acute glomerulonephritis. Clin Nephrol. 2002 Mar; 57(3):175-82.
    View in: PubMed
    Score: 0.027
  23. Wang CS, Troost JP, Wang Y, Greenbaum LA, Gibson K, Trachtman H, Srivastava T, Reidy K, Kaskel F, Sethna CB, Meyers K, Dell KM, Tran CL, Hingorani S, Lemley KV, Lin JJ, Gipson DS. Determinants of medication adherence in childhood nephrotic syndrome and associations of adherence with clinical outcomes. Pediatr Nephrol. 2022 07; 37(7):1585-1595.
    View in: PubMed
    Score: 0.027
  24. Muff-Luett M, Sanderson KR, Engen RM, Zahr RS, Wenderfer SE, Tran CL, Sharma S, Cai Y, Ingraham S, Winnicki E, Weaver DJ, Hunley TE, Kiessling SG, Seamon M, Woroniecki R, Miyashita Y, Xiao N, Omoloja AA, Kizilbash SJ, Mansuri A, Kallash M, Yu Y, Sherman AK, Srivastava T, Nester CM. Eculizumab exposure in children and young adults: indications, practice patterns, and outcomes-a Pediatric Nephrology Research Consortium study. Pediatr Nephrol. 2021 08; 36(8):2349-2360.
    View in: PubMed
    Score: 0.025
  25. Srivastava T, Garola RE, Whiting JM, Alon US. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int. 2001 Jan; 59(1):118-25.
    View in: PubMed
    Score: 0.025
  26. Charlton JR, Tan W, Daouk G, Teot L, Rosen S, Bennett KM, Cwiek A, Nam S, Emma F, Jouret F, Oliveira JP, Tranebj?rg L, Frykholm C, Mane S, Hildebrandt F, Srivastava T, Storm T, Christensen EI, Nielsen R. Beyond the tubule: pathological variants of LRP2, encoding the megalin receptor, result in glomerular loss and early progressive chronic kidney disease. Am J Physiol Renal Physiol. 2020 12 01; 319(6):F988-F999.
    View in: PubMed
    Score: 0.025
  27. Srivastava T, Alon US. Bisphosphonates: from grandparents to grandchildren. Clin Pediatr (Phila). 1999 Dec; 38(12):687-702.
    View in: PubMed
    Score: 0.023
  28. Sebestyen VanSickle J, Srivastava T, Garg U, Rezaiekhaligh MH, Alon US. Comparing directly measured versus mathematically calculated free serum 25-hydroxy vitamin D level in children. J Bone Miner Metab. 2020 Mar; 38(2):271-274.
    View in: PubMed
    Score: 0.023
  29. Srivastava T, Zwick DL, Rothberg PG, Warady BA. Posttransplant lymphoproliferative disorder in pediatric renal transplantation. Pediatr Nephrol. 1999 Nov; 13(9):748-54.
    View in: PubMed
    Score: 0.023
  30. Zahr RS, Yee ME, Weaver J, Twombley K, Matar RB, Aviles D, Sreedharan R, Rheault MN, Malatesta-Muncher R, Stone H, Srivastava T, Kapur G, Baddi P, Volovelsky O, Pelletier J, Gbadegesin R, Seeherunvong W, Patel HP, Greenbaum LA. Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2019 08; 34(8):1435-1445.
    View in: PubMed
    Score: 0.022
  31. Canetta PA, Troost JP, Mahoney S, Kogon AJ, Carlozzi N, Bartosh SM, Cai Y, Davis TK, Fernandez H, Fornoni A, Gbadegesin RA, Herreshoff E, Mahan JD, Nachman PH, Selewski DT, Sethna CB, Srivastava T, Tuttle KR, Wang CS, Falk RJ, Gharavi AG, Gillespie BW, Greenbaum LA, Holzman LB, Kretzler M, Robinson BM, Smoyer WE, Guay-Woodford LM, Reeve B, Gipson DS. Health-related quality of life in glomerular disease. Kidney Int. 2019 05; 95(5):1209-1224.
    View in: PubMed
    Score: 0.022
  32. Srivastava T, Simon SD, Alon US. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr Nephrol. 1999 Jan; 13(1):13-8.
    View in: PubMed
    Score: 0.022
  33. Wang CS, Travers C, McCracken C, Leong T, Gbadegesin R, Quiroga A, Benfield MR, Hidalgo G, Srivastava T, Lo M, Yadin O, Mathias R, Araya CE, Khalid M, Orjuela A, Zaritsky J, Al-Akash S, Kamel M, Greenbaum LA. Adrenocorticotropic Hormone for Childhood Nephrotic Syndrome: The ATLANTIS Randomized Trial. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1859-1865.
    View in: PubMed
    Score: 0.022
  34. Trachtman H, Nelson P, Adler S, Campbell KN, Chaudhuri A, Derebail VK, Gambaro G, Gesualdo L, Gipson DS, Hogan J, Lieberman K, Marder B, Meyers KE, Mustafa E, Radhakrishnan J, Srivastava T, Stepanians M, Tesar V, Zhdanova O, Komers R. DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS. J Am Soc Nephrol. 2018 11; 29(11):2745-2754.
    View in: PubMed
    Score: 0.021
  35. Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. Pediatr Nephrol. 2018 10; 33(10):1773-1780.
    View in: PubMed
    Score: 0.021
  36. VanSickle JS, Srivastava T, Alon US. Use of calcimimetics in children with normal kidney function. Pediatr Nephrol. 2019 03; 34(3):413-422.
    View in: PubMed
    Score: 0.021
  37. Adeyemo A, Esezobor C, Solarin A, Abeyagunawardena A, Kari JA, El Desoky S, Greenbaum LA, Kamel M, Kallash M, Silva C, Young A, Hunley TE, de Jesus-Gonzalez N, Srivastava T, Gbadegesin R. HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome. Am J Kidney Dis. 2018 03; 71(3):399-406.
    View in: PubMed
    Score: 0.020
  38. Sethna CB, Meyers KEC, Mariani LH, Psoter KJ, Gadegbeku CA, Gibson KL, Srivastava T, Kretzler M, Brady TM. Blood Pressure and Visit-to-Visit Blood Pressure Variability Among Individuals With Primary Proteinuric Glomerulopathies. Hypertension. 2017 08; 70(2):315-323.
    View in: PubMed
    Score: 0.020
  39. Gbadegesin RA, Adeyemo A, Webb NJ, Greenbaum LA, Abeyagunawardena A, Thalgahagoda S, Kale A, Gipson D, Srivastava T, Lin JJ, Chand D, Hunley TE, Brophy PD, Bagga A, Sinha A, Rheault MN, Ghali J, Nicholls K, Abraham E, Janjua HS, Omoloja A, Barletta GM, Cai Y, Milford DD, O'Brien C, Awan A, Belostotsky V, Smoyer WE, Homstad A, Hall G, Wu G, Nagaraj S, Wigfall D, Foreman J, Winn MP. HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome. J Am Soc Nephrol. 2015 Jul; 26(7):1701-10.
    View in: PubMed
    Score: 0.016
  40. Straatmann C, Ayoob R, Gbadegesin R, Gibson K, Rheault MN, Srivastava T, Tran CL, Gipson DS, Greenbaum LA, Smoyer WE, Vehaskari VM. Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium. Pediatr Nephrol. 2013 Aug; 28(8):1235-41.
    View in: PubMed
    Score: 0.015
  41. Penido MG, Srivastava T, Alon US. Pediatric primary urolithiasis: 12-year experience at a Midwestern Children's Hospital. J Urol. 2013 Apr; 189(4):1493-7.
    View in: PubMed
    Score: 0.014
  42. Hogg RJ, Friedman A, Greene T, Radeva M, Budisavljevic MN, Gassman J, Gipson DS, Jefferson JA, John EG, Kaskel FJ, Moudgil A, Moxey-Mims M, Ortiz LA, Schelling JR, Schnaper W, Srivastava T, Trachtman H, Vehaskari VM, Wong C, Woronieki RP, Van Why SK, Zolotnitskaya A. Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol. 2013 Feb; 8(2):211-8.
    View in: PubMed
    Score: 0.014
  43. Sebestyen JF, Srivastava T, Alon US. Bisphosphonates use in children. Clin Pediatr (Phila). 2012 Nov; 51(11):1011-24.
    View in: PubMed
    Score: 0.014
  44. Winston MJ, Srivastava T, Jarka D, Alon US. Bisphosphonates for pain management in children with benign cartilage tumors. Clin J Pain. 2012 Mar-Apr; 28(3):268-72.
    View in: PubMed
    Score: 0.014
  45. Auron A, Tal L, Srivastava T, Alon US. Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates. Pediatr Nephrol. 2009 Mar; 24(3):613-7.
    View in: PubMed
    Score: 0.011
  46. Waterhouse KM, Auron A, Srivastava T, Haney C, Alon US. Sustained beneficial effect of intravenous bisphosphonates after their discontinuation in children. Pediatr Nephrol. 2007 Feb; 22(2):282-7.
    View in: PubMed
    Score: 0.009
  47. Simckes AM, Srivastava T, Alon US. Ambulatory blood pressure monitoring in children and adolescents. Clin Pediatr (Phila). 2002 Oct; 41(8):549-64.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.